Literature DB >> 29907690

ZNF341 controls STAT3 expression and thereby immunocompetence.

Stefanie Frey-Jakobs1, Julia M Hartberger1, Manfred Fliegauf1, Claudia Bossen1, Magdalena L Wehmeyer1, Johanna C Neubauer1, Alla Bulashevska1, Michele Proietti1, Philipp Fröbel1, Christina Nöltner1, Linlin Yang1, Jessica Rojas-Restrepo1, Niko Langer1, Sandra Winzer1, Karin R Engelhardt2, Cristina Glocker1, Dietmar Pfeifer3, Adi Klein4, Alejandro A Schäffer5, Irina Lagovsky6,7, Idit Lachover-Roth8, Vivien Béziat9,10, Anne Puel9,10,11, Jean-Laurent Casanova9,10,11,12,13, Bernhard Fleckenstein14, Stephan Weidinger15, Sara S Kilic16, Ben-Zion Garty6,17, Amos Etzioni18, Bodo Grimbacher19,20,21.   

Abstract

Signal transducer and activator of transcription 3 (STAT3) is a central regulator of immune homeostasis. STAT3 levels are strictly controlled, and STAT3 impairment contributes to several diseases including the monogenic autosomal-dominant hyper-immunoglobulin E (IgE) syndrome (AD-HIES). We investigated patients of four consanguineous families with an autosomal-recessive disorder resembling the phenotype of AD-HIES, with symptoms of immunodeficiency, recurrent infections, skeletal abnormalities, and elevated IgE. Patients presented with reduced STAT3 expression and diminished T helper 17 cell numbers, in absence of STAT3 mutations. We identified two distinct homozygous nonsense mutations in ZNF341, which encodes a zinc finger transcription factor. Wild-type ZNF341 bound to and activated the STAT3 promoter, whereas the mutant variants showed impaired transcriptional activation, partly due to nuclear translocation failure. In summary, nonsense mutations in ZNF341 account for the STAT3-like phenotype in four autosomal-recessive kindreds. Thus, ZNF341 is a previously unrecognized regulator of immune homeostasis.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29907690      PMCID: PMC6173313          DOI: 10.1126/sciimmunol.aat4941

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  52 in total

1.  Functional STAT3 deficiency compromises the generation of human T follicular helper cells.

Authors:  Cindy S Ma; Danielle T Avery; Anna Chan; Marcel Batten; Jacinta Bustamante; Stephanie Boisson-Dupuis; Peter D Arkwright; Alexandra Y Kreins; Diana Averbuch; Dan Engelhard; Klaus Magdorf; Sara S Kilic; Yoshiyuki Minegishi; Shigeaki Nonoyama; Martyn A French; Sharon Choo; Joanne M Smart; Jane Peake; Melanie Wong; Paul Gray; Matthew C Cook; David A Fulcher; Jean-Laurent Casanova; Elissa K Deenick; Stuart G Tangye
Journal:  Blood       Date:  2012-03-08       Impact factor: 22.113

2.  Role of HMGB1 in regulation of STAT3 expression in CD4(+) T cells from patients with aGVHD after allogeneic hematopoietic stem cell transplantation.

Authors:  Ya-Jing Xu; Lin Li; Yan Chen; Bin Fu; Deng-Shu Wu; Xiao-Lin Li; Xie-Lan Zhao; Fang-Ping Chen
Journal:  Clin Immunol       Date:  2015-08-29       Impact factor: 3.969

3.  Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation.

Authors:  Eleanor Higgins; Tariq Al Shehri; Maeve A McAleer; Niall Conlon; Conleth Feighery; Desa Lilic; Alan D Irvine
Journal:  J Allergy Clin Immunol       Date:  2015-02       Impact factor: 10.793

4.  KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas.

Authors:  Yingduan Cheng; Hua Geng; Suk Hang Cheng; Pei Liang; Yan Bai; Jisheng Li; Gopesh Srivastava; Margaret H L Ng; Tatsuo Fukagawa; Xiushan Wu; Anthony T C Chan; Qian Tao
Journal:  Cancer Res       Date:  2010-08-03       Impact factor: 12.701

5.  Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment.

Authors:  Yu Zhang; Xiaomin Yu; Mie Ichikawa; Jonathan J Lyons; Shrimati Datta; Ian T Lamborn; Huie Jing; Emily S Kim; Matthew Biancalana; Lynne A Wolfe; Thomas DiMaggio; Helen F Matthews; Sarah M Kranick; Kelly D Stone; Steven M Holland; Daniel S Reich; Jason D Hughes; Huseyin Mehmet; Joshua McElwee; Alexandra F Freeman; Hudson H Freeze; Helen C Su; Joshua D Milner
Journal:  J Allergy Clin Immunol       Date:  2014-02-28       Impact factor: 10.793

Review 6.  Janus kinases in immune cell signaling.

Authors:  Kamran Ghoreschi; Arian Laurence; John J O'Shea
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

7.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

Authors:  Julie Toubiana; Satoshi Okada; Julia Hiller; Matias Oleastro; Macarena Lagos Gomez; Juan Carlos Aldave Becerra; Marie Ouachée-Chardin; Fanny Fouyssac; Katta Mohan Girisha; Amos Etzioni; Joris Van Montfrans; Yildiz Camcioglu; Leigh Ann Kerns; Bernd Belohradsky; Stéphane Blanche; Aziz Bousfiha; Carlos Rodriguez-Gallego; Isabelle Meyts; Kai Kisand; Janine Reichenbach; Ellen D Renner; Sergio Rosenzweig; Bodo Grimbacher; Frank L van de Veerdonk; Claudia Traidl-Hoffmann; Capucine Picard; Laszlo Marodi; Tomohiro Morio; Masao Kobayashi; Desa Lilic; Joshua D Milner; Steven Holland; Jean-Laurent Casanova; Anne Puel
Journal:  Blood       Date:  2016-04-25       Impact factor: 22.113

9.  Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder.

Authors:  Francisca Millan; Megan T Cho; Kyle Retterer; Kristin G Monaghan; Renkui Bai; Patrik Vitazka; David B Everman; Brooke Smith; Brad Angle; Victoria Roberts; LaDonna Immken; Honey Nagakura; Marc DiFazio; Elliott Sherr; Eden Haverfield; Bethany Friedman; Aida Telegrafi; Jane Juusola; Wendy K Chung; Sherri Bale
Journal:  Am J Med Genet A       Date:  2016-05-02       Impact factor: 2.578

10.  Chronic mucocutaneous candidiasis: characterization of a family with STAT-1 gain-of-function and development of an ex-vivo assay for Th17 deficiency of diagnostic utility.

Authors:  F Dhalla; H Fox; E E Davenport; R Sadler; C Anzilotti; P A van Schouwenburg; B Ferry; H Chapel; J C Knight; S Y Patel
Journal:  Clin Exp Immunol       Date:  2016-02-09       Impact factor: 4.330

View more
  40 in total

Review 1.  The genetic basis of pneumococcal and staphylococcal infections: inborn errors of human TLR and IL-1R immunity.

Authors:  Bertrand Boisson
Journal:  Hum Genet       Date:  2020-01-24       Impact factor: 4.132

Review 2.  Insights into immunity from clinical and basic science studies of DOCK8 immunodeficiency syndrome.

Authors:  Helen C Su; Huie Jing; Pam Angelus; Alexandra F Freeman
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

3.  Autosomal Dominant Hyper-IgE Syndrome Without Significantly Elevated IgE.

Authors:  Carsten S Larsen; Mette Christiansen; Trine H Mogensen
Journal:  J Clin Immunol       Date:  2019-08-29       Impact factor: 8.317

Review 4.  Human hyper-IgE syndrome: singular or plural?

Authors:  Qian Zhang; Bertrand Boisson; Vivien Béziat; Anne Puel; Jean-Laurent Casanova
Journal:  Mamm Genome       Date:  2018-08-09       Impact factor: 2.957

5.  Impaired angiogenesis and extracellular matrix metabolism in autosomal-dominant hyper-IgE syndrome.

Authors:  Natalia I Dmitrieva; Avram D Walts; Dai Phuong Nguyen; Alex Grubb; Xue Zhang; Xujing Wang; Xianfeng Ping; Hui Jin; Zhen Yu; Zu-Xi Yu; Dan Yang; Robin Schwartzbeck; Clifton L Dalgard; Beth A Kozel; Mark D Levin; Russell H Knutsen; Delong Liu; Joshua D Milner; Diego B López; Michael P O'Connell; Chyi-Chia Richard Lee; Ian A Myles; Amy P Hsu; Alexandra F Freeman; Steven M Holland; Guibin Chen; Manfred Boehm
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

6.  Efficacy of Dupilumab for Controlling Severe Atopic Dermatitis in a Patient with Hyper-IgE Syndrome.

Authors:  Romain Lévy; Vivien Béziat; Claire Barbieux; Anne Puel; Emmanuelle Bourrat; Jean-Laurent Casanova; Alain Hovnanian
Journal:  J Clin Immunol       Date:  2020-01-28       Impact factor: 8.317

7.  Cancer Tendency in a Patient with ZNF341 Deficiency.

Authors:  Sukru Cekic; Julia Maria Hartberger; Stefanie Frey-Jakobs; Huzeyfe Huriyet; Melika Bektas Hortoglu; Johanna Charlotte Neubauer; Yasin Karali; Candan Demiroz Abakay; Ozlem Saraydaroglu; Tolga Cavas; Bodo Grimbacher; Sara Sebnem Kilic
Journal:  J Clin Immunol       Date:  2020-01-24       Impact factor: 8.317

Review 8.  Human inborn errors of immunity underlying superficial or invasive candidiasis.

Authors:  Anne Puel
Journal:  Hum Genet       Date:  2020-03-02       Impact factor: 4.132

9.  A deep intronic splice mutation of STAT3 underlies hyper IgE syndrome by negative dominance.

Authors:  Joëlle Khourieh; Geetha Rao; Tanwir Habib; Danielle T Avery; Alain Lefèvre-Utile; Marie-Olivia Chandesris; Aziz Belkadi; Maya Chrabieh; Hanan Alwaseem; Virginie Grandin; Françoise Sarrot-Reynauld; Agathe Sénéchal; Olivier Lortholary; Xiao-Fei Kong; Stéphanie Boisson-Dupuis; Capucine Picard; Anne Puel; Vivien Béziat; Qian Zhang; Laurent Abel; Henrik Molina; Nico Marr; Stuart G Tangye; Jean-Laurent Casanova; Bertrand Boisson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

Review 10.  Who regulates whom: ZNF341 is an additional player in the STAT3/TH17 song.

Authors:  Avery August
Journal:  Sci Immunol       Date:  2018-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.